A Custom ALS Drug Took Three Years to Build and One Year to Normalise One Man’s Neurofilament
Built in about three years for one mutation, it normalised a biomarker in one man. A larger cohort sits outside the paper.
NeuroPulse
DealPulse Signal
The Beats
Analysis
The Briefs
A Custom ALS Drug Took Three Years to Build and One Year to Normalise One Man’s Neurofilament
UnitedHealthcare Is Enlisting Doctors Against the Paperwork Behind 43% of Projected Medicaid Losses
China Ordered Rare Disease Clinics in Every Province by December and Left Payment Out
Merck Moved Every Japanese Keytruda Indication to a One-Minute Injection on a Single Lung Cancer Trial
Telix Is Paying $1.65 Billion for ITM Without Handing the Sellers Any Cash at Closing